New study tracks blood sugar in diabetic cancer patients during chemo
NCT ID NCT04315857
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at 103 diabetic adults starting chemotherapy for cancer. Researchers used a continuous glucose monitor (Freestyle Libre) to track blood sugar changes. The goal was to see how often blood sugar went too low or too high during treatment, since chemotherapy and related medications can affect glucose levels.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
103 people
The number who actually took part.
- Started
-
Jun 2020
- Finished
-
Apr 2022
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
diabetic patients starting chemotherapy
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Person who has provided oral consent * Diabetic cancer patient starting chemotherapy for the first time or after a period of remission of at least 6 months. Exclusion Criteria: * Person not affiliated to French National Health Insurance * Person subject to legal protection (guardianship, trusteeship) * Person subject to partial justice safeguard measure * Pregnant, parturient or breastfeeding woman * Adult unable to provide consent * Minor
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Chu Dijon Bourgogne
Dijon, 21000, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can colorectal surgery patients go home in two days?
- Can a personal navigator help young cancer patients through treatment?
- Can a simple breathing pattern calm chemotherapy anxiety and improve sleep?
- Can a smartwatch predict which cancer patients return to hospital?
- New pill takes aim at blood sugar in diabetes
- Home c-peptide tests could reveal hidden insulin production in diabetes